- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
235 publications
2021
Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America.
Viruses
PubMed • Publisher's site2021
The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
Frontiers in endocrinology
PubMed • Publisher's site2021
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Science immunology
PubMed • Publisher's site2020
<p>Ocular Manifestations of Sarcoidosis in a South Florida Population</p>
Clinical Ophthalmology
Publisher's site2020
Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model
Scientific Reports
PubMed • Publisher's site